Cargando…
Activate or Inhibit? Implications of Autophagy Modulation as a Therapeutic Strategy for Alzheimer’s Disease
Neurodegenerative diseases result in a range of conditions depending on the type of proteinopathy, genes affected or the location of the degeneration in the brain. Proteinopathies such as senile plaques and neurofibrillary tangles in the brain are prominent features of Alzheimer’s disease (AD). Auto...
Autores principales: | Krishnan, Sharmeelavathi, Shrestha, Yasaswi, Jayatunga, Dona P. W., Rea, Sarah, Martins, Ralph, Bharadwaj, Prashant |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7554997/ https://www.ncbi.nlm.nih.gov/pubmed/32937909 http://dx.doi.org/10.3390/ijms21186739 |
Ejemplares similares
-
Mitoprotective Effects of a Synergistic Nutraceutical Combination: Basis for a Prevention Strategy Against Alzheimer’s Disease
por: Jayatunga, Dona P. W., et al.
Publicado: (2022) -
Autophagy Modulation as a Treatment of Amyloid Diseases
por: Mputhia, Zoe, et al.
Publicado: (2019) -
Therapeutic Potential of Mitophagy-Inducing Microflora Metabolite, Urolithin A for Alzheimer’s Disease
por: Jayatunga, Dona Pamoda W., et al.
Publicado: (2021) -
Aβ aggregation and possible implications in Alzheimer's disease pathogenesis
por: Bharadwaj, Prashant R, et al.
Publicado: (2009) -
A Synergistic Combination of DHA, Luteolin, and Urolithin A Against Alzheimer’s Disease
por: Jayatunga, Dona P. W., et al.
Publicado: (2022)